March 3, 2014Open Access

In vitro hypercoagulability on whole blood thromboelastometry associated with in vivo reduction of circulating red cell mass in dogs

Key Points

Key points are not available for this paper at this time.

Abstract

Transiently decreased RCM in vivo was accompanied by TEM variables indicating hypercoagulability, which was not confirmed by other coagulation variables. This suggests an artifact of TEM, which presents a potential limitation of this technology in patient populations with abnormal RCM.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

McMichael et al. (Mon,) studied this question.

synapsesocial.com/papers/69d6ceada0177bf533ed914c https://doi.org/https://doi.org/10.1111/vcp.12127

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Hemostatic Biomarkers in Dogs with chronic Congestive Heart Failure2007 · 51 citations
2Evidence of hypercoagulability in dogs with parvoviral enteritis2000 · 215 citations
3Hemostatic Biomarkers in Dogs with Chronic Congestive Heart Failure2007 · 46 citations
4Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs2007 · 131 citations
5Treatment of EHV-1 infection using RNA interference2008 · 7 citations

Bookmark

View Full Paper